Guizhou Sanli Pharmaceutical Co Ltd (603439) — Capital Reinvestment Ratio
Guizhou Sanli Pharmaceutical Co Ltd (603439) has a Capital Reinvestment Ratio of 0.22x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥33.19 Million) in capital expenditures (CN¥7.40 Million). See Guizhou Sanli Pharmaceutical Co Ltd (603439) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Guizhou Sanli Pharmaceutical Co Ltd Capital Reinvestment Ratio (2013–2024)
This chart tracks Guizhou Sanli Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 12 annual periods. Check Guizhou Sanli Pharmaceutical Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Guizhou Sanli Pharmaceutical Co Ltd (2013–2024)
Year-by-year Capital Reinvestment Ratio for Guizhou Sanli Pharmaceutical Co Ltd from 2013 to 2024. For live market cap and broader valuation context, see 603439 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.42x | CN¥107.07 Million | CN¥45.20 Million | ▲ +7.4% |
| 2023 | 0.39x | CN¥276.70 Million | CN¥108.73 Million | ▼ -3.9% |
| 2022 | 0.41x | CN¥293.29 Million | CN¥119.91 Million | ▲ +143.1% |
| 2021 | 0.17x | CN¥155.04 Million | CN¥26.08 Million | ▼ -79.4% |
| 2020 | 0.82x | CN¥63.25 Million | CN¥51.71 Million | ▲ +1086.3% |
| 2019 | 0.07x | CN¥116.24 Million | CN¥8.01 Million | ▲ +190.9% |
| 2018 | 0.02x | CN¥75.35 Million | CN¥1.78 Million | ▼ -81.0% |
| 2017 | 0.12x | CN¥57.47 Million | CN¥7.17 Million | ▼ -64.6% |
| 2016 | 0.35x | CN¥35.10 Million | CN¥12.36 Million | ▼ -76.8% |
| 2015 | 1.52x | CN¥33.28 Million | CN¥50.53 Million | ▼ -96.7% |
| 2014 | 46.66x | CN¥563.46K | CN¥26.29 Million | ▲ +15913.9% |
| 2013 | 0.29x | CN¥30.09 Million | CN¥8.77 Million | — |